In-depth, public interest health journalism.

What it means to build genomics capacity in Africa

During the COVID-19 pandemic, we saw the remarkable power of genomics in helping us keep track of new viral variants. Several scientists argue that Africa should continue to invest in genomics to support disease control and public health. Sue Segar asks what this means in practice and why it is considered so critically important.

OPINION: Going Local in Health Innovation – It is time and we are ready

Posted in: COVID-19, Latest

The COVID-19 pandemic has reinforced the need to think global and build locally. The African innovative pharmaceutical sector has the potential to thrive and needs more incentive to grow. A blooming continental sector would serve as a critical and secure source for key vaccines and therapeutics, reducing the need to rely on the goodwill of donors, writes Professor Kelly Chibale.